Clinical Trial Update: A Second Study to Determine the Effect of GSK256073A on HVTs [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports the completion of a second study evaluating the effect of GSK256073A on HVTs in healthy subjects and individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• GSK256073A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Dyslipidaemias | Phase 1 | Status: COMPLETED